Expert consensus on laparoscopic and robotic-assisted pancreatoduodenectomy with resection and reconstruction of portal-superior mesenteric vein (2025).
10.3760/cma.j.cn112139-20250303-00106
- Collective Name:Study Group of Minimally Invasive Treatment for Pancreatic Cancer in China Anti-Cancer Association
- Publication Type:Consensus Development Conference
- MeSH:
Humans;
Pancreaticoduodenectomy/methods*;
Mesenteric Veins/surgery*;
Laparoscopy;
Portal Vein/surgery*;
Robotic Surgical Procedures;
Pancreatic Neoplasms/surgery*;
Consensus
- From:
Chinese Journal of Surgery
2025;63(6):461-470
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatoduodenectomy with portal-superior mesenteric vein resection and reconstruction can provide radical surgical opportunities for patients with venous invasion and enable them to benefit from the surgery. With the development of minimally invasive concepts and surgical techniques, laparoscopic and robot-assisted pancreatoduodenectomy with portal-superior mesenteric vein resection and reconstruction is being increasingly widely carried out. This surgical procedure is highly technically demanding, and the perioperative management of patients is complex. However, there is a lack of high-quality and high-level evidence-based clinical studies in this regard. In order to better standardize the clinical application of laparoscopic or robot-assisted pancreatoduodenectomy with portal-superior mesenteric vein resection and reconstruction in China, the Study Group of Minimally Invasive Treatment for Pancreatic Cancer in China Anti-Cancer Association, guided by problems and based on evidence, formed 17 recommendations through full discussions among experts. The recommendations involve the safety, oncological benefits, and perioperative patient management of the minimally invasive approach to pancreatoduodenectomy with portal-superior mesenteric vein resection and reconstruction.
